The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ziprasidone-Global Market Insights and Sales Trends 2025
Synopsis
Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic that is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its immediate release intramuscular injection form is approved for acute agitation in people with schizophrenia.
The global Ziprasidone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ziprasidone in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Ziprasidone market. Oral Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Ziprasidone market, driven by demand from China, the second largest economy with some signs of stabilising, the Ziprasidone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ziprasidone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ziprasidone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ziprasidone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ziprasidone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ziprasidone covered in this report include Pfizer, Sandoz, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Apotex, Dr. Reddy's Laboratories, Wockhardt, Aurobindo and Macleods Pharmaceuticals, etc.
The global Ziprasidone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Sandoz
Lupin Pharmaceuticals
Mylan Pharmaceuticals
Apotex
Dr. Reddy's Laboratories
Wockhardt
Aurobindo
Macleods Pharmaceuticals
Zydus Pharmaceuticals
Global Ziprasidone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ziprasidone market, Segment by Type:
Oral Capsule
Injection
Global Ziprasidone market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ziprasidone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ziprasidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic that is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its immediate release intramuscular injection form is approved for acute agitation in people with schizophrenia.
The global Ziprasidone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ziprasidone in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Ziprasidone market. Oral Capsule, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Ziprasidone market, driven by demand from China, the second largest economy with some signs of stabilising, the Ziprasidone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ziprasidone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ziprasidone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ziprasidone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ziprasidone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ziprasidone covered in this report include Pfizer, Sandoz, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Apotex, Dr. Reddy's Laboratories, Wockhardt, Aurobindo and Macleods Pharmaceuticals, etc.
The global Ziprasidone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Sandoz
Lupin Pharmaceuticals
Mylan Pharmaceuticals
Apotex
Dr. Reddy's Laboratories
Wockhardt
Aurobindo
Macleods Pharmaceuticals
Zydus Pharmaceuticals
Global Ziprasidone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ziprasidone market, Segment by Type:
Oral Capsule
Injection
Global Ziprasidone market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ziprasidone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ziprasidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Ziprasidone Market Overview
1.1 Ziprasidone Product Overview
1.2 Ziprasidone Market Segment by Type
1.2.1 Oral Capsule
1.2.2 Injection
1.3 Global Ziprasidone Market Size by Type
1.3.1 Global Ziprasidone Market Size Overview by Type (2018-2029)
1.3.2 Global Ziprasidone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Ziprasidone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ziprasidone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Ziprasidone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Ziprasidone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Ziprasidone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Ziprasidone Sales Breakdown by Type (2018-2023)
2 Global Ziprasidone Market Competition by Company
2.1 Global Top Players by Ziprasidone Sales (2018-2023)
2.2 Global Top Players by Ziprasidone Revenue (2018-2023)
2.3 Global Top Players by Ziprasidone Price (2018-2023)
2.4 Global Top Manufacturers Ziprasidone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ziprasidone Market Competitive Situation and Trends
2.5.1 Ziprasidone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Ziprasidone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ziprasidone as of 2022)
2.7 Date of Key Manufacturers Enter into Ziprasidone Market
2.8 Key Manufacturers Ziprasidone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ziprasidone Status and Outlook by Region
3.1 Global Ziprasidone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Ziprasidone Historic Market Size by Region
3.2.1 Global Ziprasidone Sales in Volume by Region (2018-2023)
3.2.2 Global Ziprasidone Sales in Value by Region (2018-2023)
3.2.3 Global Ziprasidone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Ziprasidone Forecasted Market Size by Region
3.3.1 Global Ziprasidone Sales in Volume by Region (2024-2029)
3.3.2 Global Ziprasidone Sales in Value by Region (2024-2029)
3.3.3 Global Ziprasidone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Ziprasidone by Application
4.1 Ziprasidone Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Ziprasidone Market Size by Application
4.2.1 Global Ziprasidone Market Size Overview by Application (2018-2029)
4.2.2 Global Ziprasidone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Ziprasidone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ziprasidone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Ziprasidone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Ziprasidone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Ziprasidone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Ziprasidone Sales Breakdown by Application (2018-2023)
5 North America Ziprasidone by Country
5.1 North America Ziprasidone Historic Market Size by Country
5.1.1 North America Ziprasidone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Ziprasidone Sales in Volume by Country (2018-2023)
5.1.3 North America Ziprasidone Sales in Value by Country (2018-2023)
5.2 North America Ziprasidone Forecasted Market Size by Country
5.2.1 North America Ziprasidone Sales in Volume by Country (2024-2029)
5.2.2 North America Ziprasidone Sales in Value by Country (2024-2029)
6 Europe Ziprasidone by Country
6.1 Europe Ziprasidone Historic Market Size by Country
6.1.1 Europe Ziprasidone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Ziprasidone Sales in Volume by Country (2018-2023)
6.1.3 Europe Ziprasidone Sales in Value by Country (2018-2023)
6.2 Europe Ziprasidone Forecasted Market Size by Country
6.2.1 Europe Ziprasidone Sales in Volume by Country (2024-2029)
6.2.2 Europe Ziprasidone Sales in Value by Country (2024-2029)
7 Asia-Pacific Ziprasidone by Region
7.1 Asia-Pacific Ziprasidone Historic Market Size by Region
7.1.1 Asia-Pacific Ziprasidone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Ziprasidone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Ziprasidone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Ziprasidone Forecasted Market Size by Region
7.2.1 Asia-Pacific Ziprasidone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Ziprasidone Sales in Value by Region (2024-2029)
8 Latin America Ziprasidone by Country
8.1 Latin America Ziprasidone Historic Market Size by Country
8.1.1 Latin America Ziprasidone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Ziprasidone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Ziprasidone Sales in Value by Country (2018-2023)
8.2 Latin America Ziprasidone Forecasted Market Size by Country
8.2.1 Latin America Ziprasidone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Ziprasidone Sales in Value by Country (2024-2029)
9 Middle East and Africa Ziprasidone by Country
9.1 Middle East and Africa Ziprasidone Historic Market Size by Country
9.1.1 Middle East and Africa Ziprasidone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Ziprasidone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Ziprasidone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Ziprasidone Forecasted Market Size by Country
9.2.1 Middle East and Africa Ziprasidone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Ziprasidone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Ziprasidone Products Offered
10.1.5 Pfizer Recent Development
10.2 Sandoz
10.2.1 Sandoz Company Information
10.2.2 Sandoz Introduction and Business Overview
10.2.3 Sandoz Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sandoz Ziprasidone Products Offered
10.2.5 Sandoz Recent Development
10.3 Lupin Pharmaceuticals
10.3.1 Lupin Pharmaceuticals Company Information
10.3.2 Lupin Pharmaceuticals Introduction and Business Overview
10.3.3 Lupin Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Lupin Pharmaceuticals Ziprasidone Products Offered
10.3.5 Lupin Pharmaceuticals Recent Development
10.4 Mylan Pharmaceuticals
10.4.1 Mylan Pharmaceuticals Company Information
10.4.2 Mylan Pharmaceuticals Introduction and Business Overview
10.4.3 Mylan Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Pharmaceuticals Ziprasidone Products Offered
10.4.5 Mylan Pharmaceuticals Recent Development
10.5 Apotex
10.5.1 Apotex Company Information
10.5.2 Apotex Introduction and Business Overview
10.5.3 Apotex Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Apotex Ziprasidone Products Offered
10.5.5 Apotex Recent Development
10.6 Dr. Reddy's Laboratories
10.6.1 Dr. Reddy's Laboratories Company Information
10.6.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.6.3 Dr. Reddy's Laboratories Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Dr. Reddy's Laboratories Ziprasidone Products Offered
10.6.5 Dr. Reddy's Laboratories Recent Development
10.7 Wockhardt
10.7.1 Wockhardt Company Information
10.7.2 Wockhardt Introduction and Business Overview
10.7.3 Wockhardt Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Wockhardt Ziprasidone Products Offered
10.7.5 Wockhardt Recent Development
10.8 Aurobindo
10.8.1 Aurobindo Company Information
10.8.2 Aurobindo Introduction and Business Overview
10.8.3 Aurobindo Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Aurobindo Ziprasidone Products Offered
10.8.5 Aurobindo Recent Development
10.9 Macleods Pharmaceuticals
10.9.1 Macleods Pharmaceuticals Company Information
10.9.2 Macleods Pharmaceuticals Introduction and Business Overview
10.9.3 Macleods Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Macleods Pharmaceuticals Ziprasidone Products Offered
10.9.5 Macleods Pharmaceuticals Recent Development
10.10 Zydus Pharmaceuticals
10.10.1 Zydus Pharmaceuticals Company Information
10.10.2 Zydus Pharmaceuticals Introduction and Business Overview
10.10.3 Zydus Pharmaceuticals Ziprasidone Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Zydus Pharmaceuticals Ziprasidone Products Offered
10.10.5 Zydus Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ziprasidone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ziprasidone Industrial Chain Analysis
11.4 Ziprasidone Market Dynamics
11.4.1 Ziprasidone Industry Trends
11.4.2 Ziprasidone Market Drivers
11.4.3 Ziprasidone Market Challenges
11.4.4 Ziprasidone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ziprasidone Distributors
12.3 Ziprasidone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
